INVESTIGATIONS AND REPORTS RESPECTING FDA REGULATION OF NEW DRUGS .2.

被引：5

作者：

HUTT, PB ^{[1
]}

机构：

[1] COVINGTON & BURLING,WASHINGTON,DC

来源：

关键词：

D O I：

10.1038/clpt.1983.92

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：674 / 687

页数：14

共 82 条

[1]

COOK J, 1980, OPE57 FDA OFF PLANN

[2] THE DECLINE IN EFFECTIVE PATENT LIFE OF NEW DRUGS [J].

EISMAN, MM ;

WARDELL, WM .

RESEARCH MANAGEMENT, 1981, 24 (01) :18-21

[3]

FEA Task Force on Compliance and Enforcement, 1977, FINAL REPORT

[4]

GRABOWSKI HG, 1976, AEI28 AM ENT I EV ST

[5]

HALPERIN J, 1982, METHODS VALIDATION F

[6]

HALPERIN J, 1981, PREDICTIONS PHARM RE

[7]

HALPERIN J, 1981, METHODS VALIDATION

[8]

Hansen R, 1979, ISSUES PHARM EC

[9]

HASS AE, 1982, OPE60 FDA OFF PLANN

[10]

HAYES AH, 1982, ORG CHANGES MERGER B